Belen Tornesi

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Nonclinical Considerations for Support of Pregnancy and Lactation in Clinical Trials.

Nonclinical Considerations for Support of Pregnancy and Lactation in Clinical Trials.

Journal: Birth defects research

Published: March 13, 2026

Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing.

Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing.

Journal: Birth defects research

Published: January 02, 2026

Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.

Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.

Journal: The Journal of antimicrobial chemotherapy

Published: October 07, 2025

New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions.

New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: June 19, 2025

Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice.

Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice.

Journal: Regulatory toxicology and pharmacology : RTP

Published: August 09, 2024

Absence of developmental and reproductive toxicity in rats, rabbits, and zebrafish embryos exposed to antimalarial drug cabamiquine.

Absence of developmental and reproductive toxicity in rats, rabbits, and zebrafish embryos exposed to antimalarial drug cabamiquine.

Journal: Birth defects research

Published: April 16, 2024

Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model.

Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model.

Journal: Antimicrobial agents and chemotherapy

Published: May 03, 2023

Integration and application of new approach methodologies in assessing the developmental hazards: Case study with an antimalarial drug.

Integration and application of new approach methodologies in assessing the developmental hazards: Case study with an antimalarial drug.

Journal: Birth defects research

Published: November 08, 2022

Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.

Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.

Journal: Biochemical pharmacology

Published: July 01, 2022

Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition.

Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition.

Journal: Birth defects research

Published: December 15, 2021

Re-orienting anti-malarial drug development to better serve pregnant women.

Re-orienting anti-malarial drug development to better serve pregnant women.

Journal: Malaria journal

Published: November 09, 2021

A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studies.

A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studies.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: June 08, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026